 The rapid increase in drug resistant infections has presented a serious challenge to antimicrobial therapies. Failure of the most potent antibiotics to kill superbugs emphasizes the urgent need to develop other control agents. Here we review the history and new development of antimicrobial peptides, amps. This article was authored by Ali Adem-Bahar and Deshengren.